Manufacturers Life Insurance Company, The Beam Therapeutics Inc. Transaction History

Manufacturers Life Insurance Company, The

$100 Billion
Q1 2025

A detailed history of Manufacturers Life Insurance Company, The transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 170,608 shares of BEAM stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

170,608

Previous 143,502 18.89%

Holding current value

$3.03 Million

Previous $3.56 Million 6.38%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$19.53 - $34.09 $529,380 - $924,043	27,106 Added 18.89%	170,608 $3.33 Million
Q4 2024 Feb 14, 2025	SELL	$21.55 - $30.35 $50,620 - $71,292	-2,349 Reduced 1.61%	143,502 $3.56 Million
Q3 2024 Nov 13, 2024	BUY	$22.57 - $33.14 $197,758 - $290,372	8,762 Added 6.39%	145,851 $3.57 Million
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $684,960 - $1.05 Million	32,279 Added 30.8%	137,089 $3.21 Million
Q1 2024 May 14, 2024	BUY	$23.46 - $45.07 $1.65 Million - $3.16 Million	70,186 Added 202.71%	104,810 $3.46 Million
Q4 2023 Feb 13, 2024	BUY	$17.69 - $30.76 $19,618 - $34,112	1,109 Added 3.31%	34,624 $942,000
Q3 2023 Nov 15, 2023	BUY	$23.01 - $32.46 $140,545 - $198,265	6,108 Added 22.29%	33,515 $806,000
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $53,567 - $65,753	1,827 Added 7.14%	27,407 $875,000
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $5,125 - $8,294	-170 Reduced 0.66%	25,410 $778,000
Q4 2022 Aug 11, 2023	BUY	$36.73 - $51.6 $12,598 - $17,698	343 Added 1.36%	25,580 $1 Million
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $12,598 - $17,698	343 Added 1.36%	25,580 $1 Million
Q3 2022 Aug 11, 2023	SELL	$39.79 - $70.31 $18,621 - $32,905	-468 Reduced 1.82%	25,237 $1.2 Million
Q3 2022 Nov 03, 2022	SELL	$39.79 - $70.31 $18,621 - $32,905	-468 Reduced 1.82%	25,237 $1.2 Million
Q2 2022 Aug 11, 2023	BUY	$29.86 - $62.36 $133,504 - $278,811	4,471 Added 21.06%	25,705 $995,000
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $133,504 - $278,811	4,471 Added 21.06%	25,705 $995,000
Q1 2022 Aug 11, 2023	SELL	$53.73 - $82.16 $224,376 - $343,100	-4,176 Reduced 16.43%	21,234 $1.22 Million
Q1 2022 May 20, 2022	SELL	$53.73 - $82.16 $242,644 - $371,034	-4,516 Reduced 17.54%	21,234 $1.22 Million
Q4 2021 Feb 16, 2022	BUY	$68.02 - $99.06 $30,813 - $44,874	453 Added 1.79%	25,750 $2.05 Million
Q3 2021 Nov 12, 2021	SELL	$84.37 - $133.6 $83,779 - $132,664	-993 Reduced 3.78%	25,297 $2.2 Million
Q2 2021 Aug 12, 2021	BUY	$64.12 - $128.71 $260,968 - $523,849	4,070 Added 18.32%	26,290 $3.38 Million
Q1 2021 May 03, 2021	SELL	$71.28 - $120.75 $99,007 - $167,721	-1,389 Reduced 5.88%	22,220 $1.78 Million
Q4 2020 Feb 12, 2021	BUY	$22.24 - $95.63 $84,801 - $364,637	3,813 Added 19.26%	23,609 $1.93 Million
Q3 2020 Nov 09, 2020	BUY	$19.0 - $30.57 $376,124 - $605,163	19,796 New	19,796 $487,000

Others Institutions Holding BEAM

# of Institutions

258

Shares Held

93.6M

Call Options Held

425K

Put Options Held

309K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.25B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Beam Therapeutics Inc. Transaction History